Twist Bioscience Corporation (TWST)
NASDAQ: TWST · IEX Real-Time Price · USD
47.32
-1.61 (-3.29%)
At close: Jul 2, 2024, 4:00 PM
47.90
+0.58 (1.23%)
After-hours: Jul 2, 2024, 7:38 PM EDT
Twist Bioscience Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Twist Bioscience stock have an average target of 46.63, with a low estimate of 27 and a high estimate of 65. The average target predicts a decrease of -1.46% from the current stock price of 47.32.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TWST stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 4 |
| Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 6 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $55 → $65 | Strong Buy | Maintains | $55 → $65 | +37.36% | Jun 13, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $53 | Strong Buy | Initiates | $53 | +12.00% | Jun 5, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $43 → $48 | Buy | Maintains | $43 → $48 | +1.44% | May 6, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $46 → $50 | Buy | Maintains | $46 → $50 | +5.66% | May 3, 2024 |
| Barclays | Barclays | Buy Maintains $40 → $45 | Buy | Maintains | $40 → $45 | -4.90% | May 3, 2024 |
Financial Forecast
Revenue This Year
309.53M
from 245.11M
Increased by 26.28%
Revenue Next Year
372.27M
from 309.53M
Increased by 20.27%
EPS This Year
-3.07
from -3.60
EPS Next Year
-2.56
from -3.07
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 323.5M | 412.9M | 519.3M | 541.7M | 627.4M |
| Avg | 309.5M | 372.3M | 445.6M | 526.2M | 609.5M |
| Low | 295.0M | 340.1M | 399.4M | 505.6M | 585.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 32.0% | 33.4% | 39.5% | 21.6% | 19.2% |
| Avg | 26.3% | 20.3% | 19.7% | 18.1% | 15.8% |
| Low | 20.3% | 9.9% | 7.3% | 13.5% | 11.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.05 | -2.15 | -1.44 | -1.83 | -1.22 |
| Avg | -3.07 | -2.56 | -2.06 | -1.77 | -1.18 |
| Low | -3.06 | -2.78 | -2.27 | -1.71 | -1.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.